Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia

NCT01189279 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia
Alopecia, Androgenetic
Baldness

Interventions

DRUG: bimatoprost Formulation A
DRUG: bimatoprost Formulation B
DRUG: bimatoprost Formulation C

Sponsor

Allergan